TCMD Stock Summary and Trading Ideas (Tactile Systems Technology | NASDAQ:TCMD)

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Tactile Systems Technology trades on the NASDAQ stock market under the symbol TCMD.

As of April 19, 2024, TCMD stock price climbed to $14.40 with 153,215 million shares trading.

TCMD has a beta of 2.56, meaning it tends to be more sensitive to market movements. TCMD has a correlation of 0.24 to the broad based SPY ETF.

TCMD has a market cap of $339.85 million. This is considered a Small Cap stock.

Last quarter Tactile Systems Technology reported $78 million in Revenue and $.37 earnings per share. This fell short of revenue expectation by $-712,500 and exceeded earnings estimates by $.15.

In the last 3 years, TCMD stock traded as high as $61.13 and as low as $6.28.

The top ETF exchange traded funds that TCMD belongs to (by Net Assets): VTI, IWM, VXF, IWO, XHE.

TCMD has underperformed the market in the last year with a price return of -18.6% while the SPY ETF gained +21.2%. TCMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +4.1% and -5.6%, respectively, while the SPY returned +4.3% and -3.5%, respectively.

TCMD support price is $13.71 and resistance is $14.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TCMD stock will trade within this expected range on the day.